Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity.

Ueno N.

Clin Med Insights Endocrinol Diabetes. 2019 Jan 22;12:1179551418825049. doi: 10.1177/1179551418825049. eCollection 2019.

2.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
3.

Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.

Hsieh MH, Lin WY, Chien HH, Chien LH, Huang CK, Yang JF, Chang NC, Huang CF, Wang CL, Chuang WL, Yu ML, Dai CY, Ho CK.

Kaohsiung J Med Sci. 2012 Sep;28(9):470-6. doi: 10.1016/j.kjms.2012.04.003. Epub 2012 Jul 7.

4.

A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.

Wu O, Leng JH, Yang FF, Yang HM, Zhang H, Li ZF, Zhang XY, Yuan CD, Li JJ, Pan Q, Liu W, Ren YJ, Liu B, Liu QM, Cao CJ.

Clin Exp Hypertens. 2018;40(1):16-21. doi: 10.1080/10641963.2017.1281940. Epub 2017 Oct 30.

PMID:
29083240
5.

[Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].

Wang LY, Wei L, Yu HY, Zhang Y, Jia WP.

Zhonghua Yi Xue Za Zhi. 2009 Feb 3;89(4):235-8. Chinese.

PMID:
19552838
6.

Residual Effect of Sodium Glucose Cotransporter 2 Inhibitor, Tofogliflozin, on Body Weight After Washout in Japanese Men With Type 2 Diabetes.

Kakuda H, Kobayashi J, Sakurai M, Takekoshi N.

J Clin Med Res. 2019 Jan;11(1):35-41. doi: 10.14740/jocmr3650. Epub 2018 Dec 3.

7.

Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.

Jarvis B, Coukell AJ.

Drugs. 1998 Oct;56(4):691-707. Review.

PMID:
9806111
8.

Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.

Shao N, Kuang HY, Hao M, Gao XY, Lin WJ, Zou W.

Diabetes Metab Res Rev. 2014 Sep;30(6):521-9. doi: 10.1002/dmrr.2561.

PMID:
24823873
9.

Predictors of long-term diabetes remission after metabolic surgery.

Lee MH, Lee WJ, Chong K, Chen JC, Ser KH, Lee YC, Chen SC.

J Gastrointest Surg. 2015 Jun;19(6):1015-21. doi: 10.1007/s11605-015-2808-1. Epub 2015 Apr 4.

PMID:
25840670
10.

The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).

Hu Y, Chen J, Yang L, Chen P, Li J, Chen L, Chen J, Huang X, Zhang Y, Bu S, Huang Q.

J Clin Transl Endocrinol. 2014 Jul 23;1(4):133-139. doi: 10.1016/j.jcte.2014.07.001. eCollection 2014 Dec.

11.

Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline Data.

Yanai H, Hakoshima M, Adachi H, Kawaguchi A, Waragai Y, Harigae T, Masui Y, Kakuta K, Hamasaki H, Katsuyama H, Kaga T, Sako A.

J Clin Med Res. 2017 Jul;9(7):605-612. doi: 10.14740/jocmr3046w. Epub 2017 May 22.

12.

Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients.

Feng P, Yu DM, Chen LM, Chang BC, Ji QD, Li SY, Zhu M, Ding SH, Zhang BZ, Wang SL, Li HT, Lin JN, Wang MJ, Guo JC, Liu J, Liu ZD, Wu ST, Yang JH.

Acta Pharmacol Sin. 2015 Feb;36(2):200-8. doi: 10.1038/aps.2014.136. Epub 2015 Jan 26.

13.

[Nutrition management in obese patients with type 2 diabetes mellitus after laparoscopic sleeve gastrectomy].

Tang W, Chen Y, Pan M, Chen L, Zhang L, Wang T, Zhang X, Zhang P, Zheng C, Yu B.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):411-416. Chinese.

PMID:
28440522
14.

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.

Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Cornér A, Bergholm R, Yki-Järvinen H.

Diabetes Care. 2008 Jan;31(1):165-9. Epub 2007 Oct 12.

PMID:
17934148
15.

Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity.

McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD.

Nutr J. 2008 Jan 28;7:4. doi: 10.1186/1475-2891-7-4.

16.

Increased Serum Dihomo-γ-linolenic Acid Levels Are Associated with Obesity, Body Fat Accumulation, and Insulin Resistance in Japanese Patients with Type 2 Diabetes.

Tsurutani Y, Inoue K, Sugisawa C, Saito J, Omura M, Nishikawa T.

Intern Med. 2018 Oct 15;57(20):2929-2935. doi: 10.2169/internalmedicine.0816-18. Epub 2018 Jun 6.

17.

Effects of total and green vegetable intakes on glycated hemoglobin A1c and triglycerides in elderly patients with type 2 diabetes mellitus: the Japanese Elderly Intervention Trial.

Takahashi K, Kamada C, Yoshimura H, Okumura R, Iimuro S, Ohashi Y, Araki A, Umegaki H, Sakurai T, Yoshimura Y, Ito H; Japanese Elderly Diabetes Intervention Trial Study Group.

Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:50-8. doi: 10.1111/j.1447-0594.2011.00812.x.

PMID:
22435940
18.

Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome.

Kakuma T, Gotoh K, Masaki T, Itateyama E, Abe N, Yoshimatsu H.

Obes Res Clin Pract. 2010 Apr-Jun;4(2):e83-e162. doi: 10.1016/j.orcp.2009.12.003.

PMID:
24345653
19.

Endoscopic Sleeve Gastroplasty Significantly Reduces Body Mass Index and Metabolic Complications in Obese Patients.

Sharaiha RZ, Kumta NA, Saumoy M, Desai AP, Sarkisian AM, Benevenuto A, Tyberg A, Kumar R, Igel L, Verna EC, Schwartz R, Frissora C, Shukla A, Aronne LJ, Kahaleh M.

Clin Gastroenterol Hepatol. 2017 Apr;15(4):504-510. doi: 10.1016/j.cgh.2016.12.012. Epub 2016 Dec 23.

PMID:
28017845
20.

Diabetes Prevention and Weight Loss with a Fully Automated Behavioral Intervention by Email, Web, and Mobile Phone: A Randomized Controlled Trial Among Persons with Prediabetes.

Block G, Azar KM, Romanelli RJ, Block TJ, Hopkins D, Carpenter HA, Dolginsky MS, Hudes ML, Palaniappan LP, Block CH.

J Med Internet Res. 2015 Oct 23;17(10):e240. doi: 10.2196/jmir.4897.

Supplemental Content

Support Center